2017
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First At-Home Treatment Device for Depression
2
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP-2–Targeted Therapy
3
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
4
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
5
